Randy Scott Longman MD
Assistant Professor, Medicine, Weill Cornell Medical College
Request Appointment
1315 York AveMezzanineNew York, NY 10021
Fax+1 212-746-8144
Overview of Dr. Longman
Dr. Randy Longman is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Weill Cornell Medicine and has been in practice 10 years. He is one of 321 doctors at New York-Presbyterian Hospital and one of 321 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 70 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2007 - 2009
Weill Cornell MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis Start of enrollment: 2020 Jan 31
Publications & Presentations
PubMed
- 1 citationsPrecision microbiota therapy for IBD: premise and promise.Manabu Nagayama, Lasha Gogokhia, Randy S Longman
Gut Microbes. 2025-12-01 - 3 citationsIgG-seq identifies immune-reactive enteric bacteria in Crohn's disease with spondyloarthritis.Grace A Maldarelli, Maeva Metz, Seun Oguntunmibi, Nancy Tran, Grace Xiang
Gut Microbes. 2025-12-01 - 1 citationsSafety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial.Brian G Feagan, Bruce E Sands, Corey A Siegel, Marla C Dubinsky, Randy S Longman
The Lancet. Gastroenterology & Hepatology. 2025-08-01
Authored Content
- Esophagitis Dissecans SuperficialisAugust 2011
Press Mentions
Study: Crohn’s Disease Investigational Treatment Shows Potential for Achieving RemissionJune 26th, 2025- Possible Biomarker Identified for Crohn’s Disease with Arthritis TypeMarch 5th, 2025
- Crohn’s Disease with Joint Inflammation Biomarker ID’dMarch 5th, 2025
- Join now to see all
Grant Support
- Agr2 regulates host-microbe responses in Crohn's diseaseWEILL MEDICAL COLL OF CORNELL UNIV2025–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Activity Probes to Guide Precision Microbiome TherapyWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- TL1A Regulation of Group 3 Innate Lymphoid Cells in ColitisWEILL MEDICAL COLL OF CORNELL UNIV2020–2029
- A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)WEILL MEDICAL COLL OF CORNELL UNIV2021–2025
- Multidisciplinary Research Training in Gastroenterology and HepatologyWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
- Multidisciplinary Research Training in Gastroenterology and HepatologyWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
